Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging

  • Authors:
    • Xiali Qin
    • Tengfei Yang
    • Zhongkui Huang
    • Liling Long
    • Zhipeng Zhou
    • Wenmei Li
    • Yinjuan Gao
    • Mengzhu Wang
    • Xiaoyong Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Magnetic Resonance Scientific Marketing, Siemens Healthineers, Guangzhou, Guangdong 510620, P.R. China
    Copyright: © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2322-2329
    |
    Published online on: July 4, 2019
       https://doi.org/10.3892/ol.2019.10557
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to explore the value of T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic (Gd‑EOB‑DTPA)‑enhanced magnetic resonance imaging (MRI) for grading hepatocellular carcinoma (HCC) and predicting its recurrence rate. A retrospective study was performed that included 75 patients (66 men and 9 women; mean age, 52.89 years; age range, 23‑79 years) with HCC who had undergone Gd‑EOB‑DTPA‑enhanced MRI with T1 mapping before surgery. The T1 relaxation time of the 81 lesions and non‑tumorous liver parenchyma in 75 patients with HCC were measured before Gd‑EOB‑DTPA was injected and then at 5, 10 and 20 min after administration, respectively. T1[lesion (L)‑hepatic parenchyma (H)]/H (%) was calculated as the increment rate of the T1 value in the lesions relative to the non‑tumorous liver parenchyma. One‑way analysis of variance and Spearman's correlation analysis was used to compare the differences and relationship of T1 mapping values among the three grades of HCC. A total of 81 lesions were divided into well‑differentiated HCC (grades I; n=21), moderately differentiated HCC (grades II; n=40) and poorly differentiated HCC (grades III; n=20) according to the histopathology. The T1(L‑H)/H (%) value among grades I, II and III HCC on pre‑contrast results and on post‑contrast results at the 5‑, 10‑ and 20‑min hepatobiliary phase (HBP) were significantly different (P<0.05), and T1(L‑H)/H (%) was correlated with the histological grade of HCC at each time point (r=0.637, r=0.554, r=0.499 and r=0.560, respectively, P<0.001). A total of 41 recurrence cases [grade I (n=5), grade II (n=23) and grade III (n=13)] were verified by imaging (CT, MRI or ultrasound) or reoperation. Patients with grade III and grade II HCC had higher recurrence rates compared with that in patients with grade I HCC (P<0.05; median recurrence times were 258 days, 605 days and undefined, respectively). According to the optimal cut‑off point for the T1(L‑H)/H (%) of the three grades of HCC, patients with HCC in the low T1(L‑H)/H (%) value group (≤155.15%) had lower cumulative recurrence rates compared with that in the medium (T1(L‑H)/H (%) >155.15% and T1(L‑H)/H (%) ≤241.20%) and high (T1(L‑H)/H (%) >241.20%) value groups at the 20‑min HBP (P<0.05; median recurrence times were undefined, 530 days and 447 days, respectively). These results indicate that the parameters of T1 mapping would be beneficial for predicting the grading and recurrence of HCC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Hu Y, Wu J, Li S and Zhao X: Correlation between CT features and liver function and p53 expression in hepatitis, cirrhosis and hepatocellular carcinoma. Oncol Lett. 16:4297–4302. 2018.PubMed/NCBI

2 

Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S and Makuuchi M: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 38:200–207. 2003. View Article : Google Scholar : PubMed/NCBI

3 

Ariizumi S, Kitagawa K, Kotera Y, Takahashi Y, Katagiri S, Kuwatsuru R and Yamamoto M: A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 18:575–585. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG and Qu Q: Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pract. 213:824–830. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Nathan H, Schulick RD, Choti MA and Pawlik TM: Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg. 249:799–805. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Kim JH, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC and Paik SW: The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma. Medicine (Baltimore). 95:e56662016. View Article : Google Scholar : PubMed/NCBI

7 

Peng Z, Jiang M, Cai H, Chan T, Dong Z, Luo Y, Li ZP and Feng ST: Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma. BMC Cancer. 16:6252016. View Article : Google Scholar : PubMed/NCBI

8 

Chang WC, Chen RC, Chou CT, Lin CY, Yu CY, Liu CH, Chou JM, Hsu HH and Huang GS: Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images. Abdom Imaging. 39:1202–1212. 2014. View Article : Google Scholar : PubMed/NCBI

9 

An C, Park MS, Jeon HM, Kim YE, Chung WS, Chung YE, Kim MJ and Kim KW: Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI. Eur Radiol. 22:1701–1708. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Nassif A, Jia J, Keiser M, Oswald S, Modess C, Nagel S, Weitschies W, Hosten N, Siegmund W and Kuhn JP: Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Radiology. 264:741–750. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Kogita S, Imai Y, Okada M, Kim T, Onishi H, Takamura M, Fukuda K, Igura T, Sawai Y, Morimoto O, et al: Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading and portal blood flow. Eur Radiol. 20:2405–2413. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Lee SA, Lee CH, Jung WY, Lee J, Choi JW, Kim KA and Park CM: Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: Initial experience. Magn Reson Imaging. 29:83–90. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Zeng MS, Ye HY, Guo L, Peng WJ, Lu JP, Teng GJ, Huan Y, Li P, Xu JR, Liang CH and Breuer J: Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: A multicenter, open-label, phase III study. Hepatobiliary Pancreat Dis Int. 12:607–616. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Park JH, Kang JH, Lee YJ, Kim KI, Lee TS, Kim KM, Park JA, Ko YO, Yu DY, Nahm SS, et al: Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: A preclinical study. Oncol Rep. 33:347–353. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Haimerl M, Verloh N, Zeman F, Fellner C, Muller-Wille R, Schreyer AG, Stroszczynski C and Wiggermann P: Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 8:e856582013. View Article : Google Scholar : PubMed/NCBI

16 

Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang LJ, Yang TF and Huang ZK: Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic. Abdom Radiol (NY). 42:2272–2278. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Ding Y, Rao SX, Zhu T, Chen CZ, Li RC and Zeng MS: Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging. Clin Radiol. 70:1096–1103. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Yoshimura N, Saito K, Saguchi T, Funatsu T, Araki Y, Akata S and Tokuuye K: Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. Magn Reson Imaging. 31:23–27. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang LJ, Yang TF and Huang ZK: Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla. BMC Med Imaging. 17:202017. View Article : Google Scholar : PubMed/NCBI

20 

Peng Z, Li C, Chan T, Cai H, Luo Y, Dong Z, Li ZP and Feng ST: Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: Differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma. Oncotarget. 8:65435–65444. 2017.PubMed/NCBI

21 

Wang WT, Zhu S, Ding Y, Yang L, Chen CZ, Ye QH, Ji Y, Zeng MS and Rao SX: T1 mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy. Eur J Radiol. 103:25–31. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Llovet JM, Fuster J and Bruix J: Prognosis of hepatocellular carcinoma. Hepatogastroenterology. 49:7–11. 2002.PubMed/NCBI

23 

Edmondson HA and Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI

24 

Bae KE, Kim SY, Lee SS, Kim KW, Won HJ, Shin YM, Kim PN and Lee MG: Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis. 30:617–622. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Zhang W, Tan Y, Jiang L, Yan L, Li B, Wen T and Yang J: Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section. Medicine (Baltimore). 96:e62462017. View Article : Google Scholar : PubMed/NCBI

26 

Liu K, Hao M, Ouyang Y, Zheng J and Chen D: CD133(+) cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma. Sci Rep. 7:414992017. View Article : Google Scholar : PubMed/NCBI

27 

Barreto SG, Brooke-Smith M, Dolan P, Wilson TG, Padbury RT and Chen JW: Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma. ANZ J Surg. 83:331–335. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Park YK, Kim BW, Wang HJ and Kim MW: Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. Transplant Proc. 41:1691–1697. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Tsuda N and Matsui O: Cirrhotic rat liver: Reference to transporter activity and morphologic changes in bile canaliculi-gadoxetic acid-enhanced MR imaging. Radiology. 256:767–773. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Norén B, Dahlström N, Forsgren MF, Dahlqvist Leinhard O, Kechagias S, Almer S, Wirell S, Smedby Ö and Lundberg P: Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease-A biopsy-verified prospective study. Eur J Radiol Open. 2:19–25. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Mori Y, Tamai H, Shingaki N, Hayami S, Ueno M, Maeda Y, Moribata K, Deguchi H, Niwa T, Inoue I, et al: Hypointense hepatocellular carcinomas on apparent diffusion coefficient mapping: Pathological features and metastatic recurrence after hepatectomy. Hepatol Res. 46:634–641. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Shen J, Liu J, Li C, Wen T, Yan L and Yang J: The impact of tumor differentiation on the prognosis of HBV-associated solitary hepatocellular carcinoma following hepatectomy: A propensity score matching analysis. Dig Dis Sci. 63:1962–1969. 2018. View Article : Google Scholar : PubMed/NCBI

33 

Kok B and Abraldes JG: Child-pugh classification: Time to abandon? Semin Liver Dis. 39:96–103. 2019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qin X, Yang T, Huang Z, Long L, Zhou Z, Li W, Gao Y, Wang M and Zhang X: Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging. Oncol Lett 18: 2322-2329, 2019.
APA
Qin, X., Yang, T., Huang, Z., Long, L., Zhou, Z., Li, W. ... Zhang, X. (2019). Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging. Oncology Letters, 18, 2322-2329. https://doi.org/10.3892/ol.2019.10557
MLA
Qin, X., Yang, T., Huang, Z., Long, L., Zhou, Z., Li, W., Gao, Y., Wang, M., Zhang, X."Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging". Oncology Letters 18.3 (2019): 2322-2329.
Chicago
Qin, X., Yang, T., Huang, Z., Long, L., Zhou, Z., Li, W., Gao, Y., Wang, M., Zhang, X."Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging". Oncology Letters 18, no. 3 (2019): 2322-2329. https://doi.org/10.3892/ol.2019.10557
Copy and paste a formatted citation
x
Spandidos Publications style
Qin X, Yang T, Huang Z, Long L, Zhou Z, Li W, Gao Y, Wang M and Zhang X: Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging. Oncol Lett 18: 2322-2329, 2019.
APA
Qin, X., Yang, T., Huang, Z., Long, L., Zhou, Z., Li, W. ... Zhang, X. (2019). Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging. Oncology Letters, 18, 2322-2329. https://doi.org/10.3892/ol.2019.10557
MLA
Qin, X., Yang, T., Huang, Z., Long, L., Zhou, Z., Li, W., Gao, Y., Wang, M., Zhang, X."Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging". Oncology Letters 18.3 (2019): 2322-2329.
Chicago
Qin, X., Yang, T., Huang, Z., Long, L., Zhou, Z., Li, W., Gao, Y., Wang, M., Zhang, X."Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium‑ethoxybenzyl diethylenetriamine pentaacetic acid‑enhanced magnetic resonance imaging". Oncology Letters 18, no. 3 (2019): 2322-2329. https://doi.org/10.3892/ol.2019.10557
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team